tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
I-Mab’s Strategic Expansion and Financial Stability Justify Buy Rating Amid Promising Clinical Developments
PremiumRatingsI-Mab’s Strategic Expansion and Financial Stability Justify Buy Rating Amid Promising Clinical Developments
26d ago
I-Mab announces accelerated investment in givastomig program
Premium
The Fly
I-Mab announces accelerated investment in givastomig program
26d ago
I-Mab Announces Leadership Changes and Accelerated Investment in Givastomig
Premium
Company Announcements
I-Mab Announces Leadership Changes and Accelerated Investment in Givastomig
26d ago
I-MAB’s Positive Outlook: Buy Rating Backed by Financial Stability and Promising Clinical Developments
PremiumRatingsI-MAB’s Positive Outlook: Buy Rating Backed by Financial Stability and Promising Clinical Developments
1M ago
I-Mab Reports Strong Financials and Clinical Progress in August 2025
Premium
Company Announcements
I-Mab Reports Strong Financials and Clinical Progress in August 2025
1M ago
I-Mab reports Q2 EPS (3c), consensus (5c)
Premium
The Fly
I-Mab reports Q2 EPS (3c), consensus (5c)
1M ago
3 Penny Stocks to Watch Now, 8/5/25
PremiumMarket News3 Penny Stocks to Watch Now, 8/5/25
2M ago
I-Mab Announces $65 Million ADS Offering to Advance Cancer Treatment Pipeline
Premium
Company Announcements
I-Mab Announces $65 Million ADS Offering to Advance Cancer Treatment Pipeline
2M ago
Everest Medicines announces strategic equity investment in I-Mab
Premium
The Fly
Everest Medicines announces strategic equity investment in I-Mab
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100